These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 15322036
1. Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components. Dagan R, Goldblatt D, Maleckar JR, Yaïch M, Eskola J. Infect Immun; 2004 Sep; 72(9):5383-91. PubMed ID: 15322036 [Abstract] [Full Text] [Related]
4. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants. Tregnaghi M, Zambrano B, Santos-Lima E. Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567 [Abstract] [Full Text] [Related]
5. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea. Lee SY, Hwang HS, Kim JH, Kim HH, Lee HS, Chung EH, Park SE, Ma SH, Chang JK, Guitton F, Ortiz E, Kang JH. Vaccine; 2011 Feb 11; 29(8):1551-7. PubMed ID: 21215828 [Abstract] [Full Text] [Related]
7. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine. Thisyakorn U, Pancharoen C, Chuenkitmongkol S, Ortiz E. Southeast Asian J Trop Med Public Health; 2009 Mar 11; 40(2):282-94. PubMed ID: 19323013 [Abstract] [Full Text] [Related]
10. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L. Pediatr Infect Dis J; 2009 Apr 11; 28(4 Suppl):S97-S108. PubMed ID: 19325452 [Abstract] [Full Text] [Related]
12. Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines. Wanlapakorn N, Sarawanangkoor N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y. Hum Vaccin Immunother; 2024 Dec 31; 20(1):2352909. PubMed ID: 38752802 [Abstract] [Full Text] [Related]
14. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM. Vaccine; 2005 May 25; 23(28):3657-67. PubMed ID: 15882526 [Abstract] [Full Text] [Related]
15. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model. Mawas F, Newman G, Burns S, Corbel MJ. J Infect Dis; 2005 Jan 01; 191(1):58-64. PubMed ID: 15593004 [Abstract] [Full Text] [Related]
16. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered. Daum RS, Zenko CE, Given GZ, Ballanco GA, Parikh H, Germino K. J Infect Dis; 2001 Nov 15; 184(10):1293-9. PubMed ID: 11679918 [Abstract] [Full Text] [Related]
17. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine. Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E. Int J Infect Dis; 2007 Nov 15; 11(6):488-95. PubMed ID: 17349809 [Abstract] [Full Text] [Related]
18. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H, Burbidge P, Thalasselis V, Hallis B, Goldblatt D, Borrow R, Heath PT, Miller E. Clin Infect Dis; 2015 Dec 01; 61(11):1637-44. PubMed ID: 26374816 [Abstract] [Full Text] [Related]
19. Immunogenicity of a Haemophilus influenzae type b-tetanus conjugate vaccine when administered separately or in combined vaccines for primary immunization in two consecutive national schedules in Turkey. Yüksel N, Beyazova U, Balci IF, Aksakal FN, Camurdan AD, Sahin F, Rota S. Int J Infect Dis; 2012 May 01; 16(5):e354-7. PubMed ID: 22387144 [Abstract] [Full Text] [Related]
20. Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of China. Li RC, Li FX, Li YP, Hou QM, Li CG, Li YN, Chen FS, Hu XZ, Su WB, Zhang SM, Fang HH, Ye Q, Zeng TD, Liu TX, Li XB, Huang YN, Deng ML, Zhang YP, Ortiz E. Vaccine; 2011 Nov 21; 29(50):9337-44. PubMed ID: 22001281 [Abstract] [Full Text] [Related] Page: [Next] [New Search]